Not logged in Share Save
Share Save
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer Wang, Haowei; Cheng, Lei; Chen, Jian; Chen, Peixin; Tang, Zhuoran; Wang, Qianyi; Ma, Ying; Zhao, Chao; Li, Xuefei; Jiang, Tao; Zhou, Fei; Chen, Xiaoxia; Zhou, Caicun Share Save
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations Hertz, Daniel L.; Joerger, Markus; Bang, Yung-Jue; Mathijssen, Ron H.; Zhou, Caicun; Zhang, Li; Gandara, David; Stahl, Michael; Monk, Bradley J.; Jaehde, Ulrich; Beumer, Jan H. Share Save
Phase I dose escalation of ASKC202, a novel cMET tyrosine kinase inhibitor, in patients with advanced solid tumors Song, Tingting; Zhou, Caicun; Li, Wei; Li, Xingya; Wu, Lin; Zeng, Shan; Miao, Liyun; Liu, Baogang; Wei, Xuyu; Chen, Jing; Han, Luwei Share Save
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC Zhou, Caicun; Solomon, Benjamin; Loong, Herbert H.; Park, Keunchil; Perol, Maurice; Arriola, Edurne; Novello, Silvia; Han, Baohui; Zhou, Jianying; Ardizzoni, Andrea; Mak, M. Perez; Santini, Fernando C.; Elamin, Yasir Y.; Drilon, Alexander; Wolf, Juergen; Payakachat, Nalin; Uh, Minji K.; Rajakumar, Deborah; Han, Hongmei; Puri, Tarun; Soldatenkova, Victoria; Lin, A. Bence; Lin, Boris K.; Goto, Koichi Share Save
Treatment patterns and clinical outcomes of patients with unresectable advanced or metastatic (UAM) gastric/gastroesophageal junction adenocarcinoma (GA/GEJA) in China: A multicenter real-world study Zhang, Y.; Zhang, J.; Xie, X.; Pan, W.; Wang, G.; Dong, Q.; Zhang, N.; Dong, J.; Segall, G.; Zhou, L.; Zhou, C.; Khanal, M.; Yang, Y.; Zeng, L. Share Save
Amivantamab plus chemotherapy vs chemotherapy as firstline treatment in EGFR Exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): Primary results from PAPILLON, a randomized phase III global study Girard, N.; Park, K.; Tang, K.; Cho, B. C.; Paz-Ares, L.; Cheng, S.; Kitazono, S.; Thiagarajan, M.; Goldman, J. W.; Sabari, J. K.; Sanborn, R. E.; Mansfield, A. S.; Hung, J-Y.; Popat, S.; Dias, J.; Bhattacharya, A.; Agrawal, T.; Shreeve, M.; Knoblauch, R. E.; Zhou, C. Share Save
Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer Fang, Qiyu; Wan, Xiaoying; D'Aiello, Angelica; Sun, Hui; Gu, Weiquing; Li, Yixue; Zhou, Caicun; Xie, Boxiong; Deng, Qinfang; Cheng, Haiying; Zhou, Songwen Share Save
Share Save
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China Tu, Hai-Yan; Feng, Jifeng; Shi, Meiqi; Zhao, Jun; Wang, Yuyan; Chang, Jianhua; Wang, Jialei; Cheng, Ying; Zhu, Jing; Tan, Eng-Huat; Li, Kai; Zhang, Yiping; Lee, Victor; Yang, Cheng-Ta; Su, Wu-Chou; Lam, David Chi-Leung; Srinivasa, B. J.; Rajappa, Senthil; Ho, Ching-Liang; Lam, Kwok Chi; Hu, Yi; Bondarde, Shailesh Arjun; Liu, Xiaoqing; Tian, Yahui; Xue, Zhiyi; Cseh, Agnieszka; Huang, Dennis Chin-Lun; Zhou, Caicun; Wu, Yi-Long Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations Yang, Shuo; Wang, Yan; Zhao, Chao; Li, Xuefei; Liu, Qian; Mao, Shiqi; Liu, Yiwei; Yu, Xiaofei; Wang, Wanying; Tian, Qinrun; Pan, Yingying; Xiong, Anwen; Chen, Bin; Gao, Guanghui; Li, Wei; He, Yayi; Wu, Fengying; Chen, Xiaoxia; Su, Chunxia; Ren, Shengxiang; Zhou, Caicun Share Save
GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an antiPDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC) Zhou, C.; Wang, Z.; Sun, Y.; Cao, L.; Ma, Z.; Wu, R.; Yu, Y.; Yao, W.; Chang, J.; Chen, J.; Zhuang, W.; Cui, J.; Chen, X.; Lu, Y.; Shen, H.; Li, P.; Wang, J.; Sun, B.; Lu, D.; Yang, J. Share Save
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients withEGFR-mutated,MET-amplified advanced non-small-cell lung cancer Yang, Jin-Ji; Fang, Jian; Shu, Yong-Qian; Chang, Jian-Hua; Chen, Gong-Yan; He, Jian Xing; Li, Wei; Liu, Xiao-Qing; Yang, Nong; Zhou, Caicun; Huang, Jian An; Frigault, Melanie M.; Hartmaier, Ryan; Ahmed, Ghada F.; Egile, Coumaran; Morgan, Shethah; Verheijen, Remy B.; Mellemgaard, Anders; Yang, Liu; Wu, Yi-Long Share Save
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations Jia, Yijun; Li, Xuefei; Zhao, Chao; Ren, Shengxiang; Su, Chunxia; Gao, Guanghui; Li, Wei; Zhou, Fei; Li, Jiayu; Zhou, Caicun Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
